+44 (0) 20 7549 9987 | USA callers: 00-1-718-682-4567

Contact Us Now
Global Wound Care market

New Advances in the Wound Care Market

14 January 2020
Pharma

wound care market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal. 

Let’s take a look at some of the most current advances in the wound care market. 

New Products in the Wound Care Market 

This year several exciting new products and applications were released, making dressing wounds easier and more efficient. The first of these, Mepilex Border Flex, was designed to create less waste while also making wound dressing easier by increasing adherence in areas prone to movement. Additionally, it’s also shown to be more comfortable than other dressings and offers a long wear time.

Another exciting product to hit the wound care market this year is Exufiber® Ag+, a gel-fiber dressing used for a variety of wound types, like leg and foot ulcers, cavity wounds, pressure ulcers, and surgical wounds. This dressing inserts a gel to increase healing and make the dressings much easier and less painful to remove 

Lastly, Mepilex Border Sacrum is a dressing used specifically to treat sacral wounds and provide ulcer prevention. Its Deep Defense technology is designed to be both strong and flexible. A host of clinical studies and trials have demonstrated both its effectiveness, as well as its economic features. 

New Research Presented in Fish-Skin Therapy 

In recent years, fish-skin therapy has grown as a new way to treat and dress wounds. This past year, medical fish skin company Kerecis presented their findings at the Symposium on Advanced Wound Care about their use of fish skin for tissue and skin cell regeneration. Their Kerecis Omega3 Wound technology utilizes intact fish skin, which converts the body’s cells and creates living tissue after being grafted onto a wound. 

Since the Kerecis fish skin used for the application is only very gently processed, it maintains most of its features and remains quite similar to human skin, creating the perfect substitute. 

Contact Visiongain for more info about the wound care market! 

If you’re a wound care dressing manufacturer, medical practitioner, or stakeholder in the wound care market, Visiongain would love to hear from you. For more than 20 years we’ve been helping businesses and key leaders get ahead of the competition and solidify their success with in-depth market data. 

Our reports and forecasts use the most current primary and secondary sources to provide you with data you can rely on to make those tough decisions. With more than 1,500 reports spanning more than 18 market verticals, it’s easy to find what you need 

For more information, contact us online today or call +44 (0) 20 7549 9987

Recent News

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

Read

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

Read

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

Read

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever